Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromuscular Agents | 3 | 2017 | 22 | 1.190 |
Why?
|
| Pyridostigmine Bromide | 2 | 2017 | 11 | 1.090 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2017 | 58 | 1.060 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2017 | 31 | 1.060 |
Why?
|
| Singing | 2 | 2016 | 5 | 1.050 |
Why?
|
| Nerve Compression Syndromes | 2 | 2018 | 16 | 0.960 |
Why?
|
| Voice Quality | 4 | 2020 | 21 | 0.960 |
Why?
|
| Dystonia | 2 | 2014 | 18 | 0.950 |
Why?
|
| Vocal Cord Paralysis | 3 | 2012 | 18 | 0.790 |
Why?
|
| Voice Disorders | 3 | 2020 | 22 | 0.780 |
Why?
|
| Laryngeal Diseases | 3 | 2018 | 22 | 0.740 |
Why?
|
| Recurrent Laryngeal Nerve | 2 | 2012 | 4 | 0.740 |
Why?
|
| Glossopharyngeal Nerve | 1 | 2018 | 1 | 0.660 |
Why?
|
| Brain Stem | 1 | 2018 | 46 | 0.650 |
Why?
|
| Deglutition Disorders | 4 | 2017 | 297 | 0.640 |
Why?
|
| Vagus Nerve | 1 | 2018 | 90 | 0.630 |
Why?
|
| Hearing Loss, High-Frequency | 1 | 2016 | 16 | 0.560 |
Why?
|
| Voice | 1 | 2016 | 16 | 0.560 |
Why?
|
| Persons With Hearing Impairments | 1 | 2016 | 22 | 0.550 |
Why?
|
| Occupational Diseases | 1 | 2016 | 68 | 0.550 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2016 | 46 | 0.540 |
Why?
|
| Auditory Perception | 1 | 2016 | 89 | 0.520 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2016 | 110 | 0.510 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2015 | 4 | 0.500 |
Why?
|
| Teaching | 1 | 2016 | 169 | 0.490 |
Why?
|
| Laryngeal Muscles | 1 | 2014 | 6 | 0.480 |
Why?
|
| Dysphonia | 1 | 2014 | 6 | 0.480 |
Why?
|
| Students | 1 | 2016 | 233 | 0.480 |
Why?
|
| Dystonic Disorders | 1 | 2014 | 9 | 0.480 |
Why?
|
| Botulinum Toxins | 1 | 2014 | 18 | 0.480 |
Why?
|
| Antidotes | 1 | 2014 | 21 | 0.480 |
Why?
|
| Papillomaviridae | 1 | 2015 | 104 | 0.470 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 91 | 0.460 |
Why?
|
| Dyspnea | 1 | 2014 | 87 | 0.450 |
Why?
|
| Papillomavirus Infections | 1 | 2015 | 194 | 0.410 |
Why?
|
| Pneumonectomy | 1 | 2012 | 79 | 0.400 |
Why?
|
| Sarcoidosis | 2 | 2010 | 77 | 0.380 |
Why?
|
| Lymphatic Diseases | 1 | 2008 | 27 | 0.310 |
Why?
|
| Retrospective Studies | 8 | 2018 | 7277 | 0.300 |
Why?
|
| Aged | 9 | 2020 | 14862 | 0.290 |
Why?
|
| Middle Aged | 9 | 2018 | 21147 | 0.270 |
Why?
|
| Female | 14 | 2020 | 38074 | 0.250 |
Why?
|
| Treatment Outcome | 6 | 2018 | 7029 | 0.250 |
Why?
|
| Male | 14 | 2020 | 37321 | 0.250 |
Why?
|
| Respiratory Muscles | 2 | 2020 | 9 | 0.230 |
Why?
|
| Adult | 9 | 2016 | 21403 | 0.230 |
Why?
|
| Humans | 19 | 2020 | 68618 | 0.230 |
Why?
|
| Gastroesophageal Reflux | 1 | 2005 | 318 | 0.210 |
Why?
|
| Young Adult | 4 | 2016 | 5717 | 0.190 |
Why?
|
| Voice Training | 2 | 2020 | 7 | 0.190 |
Why?
|
| Postoperative Complications | 3 | 2018 | 1615 | 0.190 |
Why?
|
| Resistance Training | 1 | 2020 | 29 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1851 | 0.180 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 3259 | 0.170 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 55 | 0.160 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2017 | 450 | 0.150 |
Why?
|
| Larynx | 2 | 2008 | 49 | 0.150 |
Why?
|
| Infant | 4 | 2017 | 2891 | 0.150 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2800 | 0.140 |
Why?
|
| Speech-Language Pathology | 1 | 2016 | 24 | 0.140 |
Why?
|
| Adolescent | 4 | 2016 | 8912 | 0.130 |
Why?
|
| Auditory Threshold | 1 | 2016 | 206 | 0.130 |
Why?
|
| Prevalence | 2 | 2017 | 1619 | 0.130 |
Why?
|
| Child | 2 | 2017 | 6405 | 0.130 |
Why?
|
| Remission Induction | 1 | 2015 | 111 | 0.120 |
Why?
|
| Palliative Care | 1 | 2017 | 271 | 0.120 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 44 | 0.120 |
Why?
|
| Injections | 1 | 2014 | 119 | 0.120 |
Why?
|
| Quality of Life | 2 | 2020 | 1515 | 0.110 |
Why?
|
| Electromyography | 1 | 2014 | 184 | 0.110 |
Why?
|
| Heart Defects, Congenital | 2 | 2017 | 596 | 0.110 |
Why?
|
| Laryngoscopy | 2 | 2017 | 61 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2020 | 3705 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2017 | 738 | 0.100 |
Why?
|
| Glottis | 1 | 2011 | 17 | 0.100 |
Why?
|
| Laryngomalacia | 1 | 2011 | 12 | 0.100 |
Why?
|
| Risk Factors | 3 | 2016 | 5731 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 955 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 43 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2279 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2223 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 4848 | 0.080 |
Why?
|
| Time Factors | 1 | 2016 | 4655 | 0.080 |
Why?
|
| United States | 2 | 2017 | 7367 | 0.070 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2005 | 23 | 0.060 |
Why?
|
| Laryngitis | 1 | 2005 | 12 | 0.060 |
Why?
|
| Sulfoxides | 1 | 2005 | 16 | 0.060 |
Why?
|
| Anti-Ulcer Agents | 1 | 2005 | 47 | 0.060 |
Why?
|
| Omeprazole | 1 | 2005 | 53 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 1140 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2005 | 128 | 0.060 |
Why?
|
| Vital Capacity | 1 | 2020 | 43 | 0.050 |
Why?
|
| Spirometry | 1 | 2020 | 47 | 0.050 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 87 | 0.050 |
Why?
|
| Phonation | 1 | 2020 | 9 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 123 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2005 | 1330 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2020 | 18 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2324 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 1342 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2017 | 152 | 0.030 |
Why?
|
| Deglutition | 1 | 2017 | 221 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 438 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2016 | 506 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 931 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2011 | 216 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2008 | 2455 | 0.020 |
Why?
|
| Hoarseness | 1 | 2010 | 6 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2010 | 63 | 0.020 |
Why?
|
| Prednisone | 1 | 2010 | 104 | 0.020 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 34 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2010 | 222 | 0.020 |
Why?
|
| Laser Therapy | 1 | 2008 | 54 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 2008 | 120 | 0.020 |
Why?
|
| Pharyngeal Diseases | 1 | 2005 | 21 | 0.020 |
Why?
|
| Endoscopy | 1 | 2008 | 464 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2008 | 3187 | 0.010 |
Why?
|